lipid-lowering medication

lipid-lowering medicationlipid-lowering medication
  1. Subjects were not taking vascular active substance and lipid-lowering medication .

    受试者未服用血管活性药物及降脂降压药物。

  2. Lipid-lowering medication reduces blood cholesterol levels , an important risk factor for CVD .

    调脂治疗降低血胆固醇水平,而后者是CVD的主要危险因素。

  3. Limitations : No participant was taking lipid-lowering medication , and diabetes was uncommon .

    局限性:没有正在服用降脂药物的患者,也几乎没有糖尿病患者。

  4. Methods : 1 . Through the biggest drug test for mice , observation made fat away lipid-lowering capsule may produce acute toxicity reaction . Opposition fat away lipid-lowering medication safety capsule . 2 .

    方法:1.通过小鼠的最大给药量试验,观察立脂消降脂胶囊可能产生的急性毒性反应,对立脂消降脂胶囊的药物安全性进行初步研究。